Harmony Biosciences Holdings Inc. – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: HRMY
Share price (10/1/26): $39.57
Market cap (10/1/26): $2.304 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K/A 118 pages Agreement and Plan of Merger by and Among Harmony Biosciences Holdings, Inc., Xylophone Acquisition Corp. and Zynerba Pharmaceuticals, Inc. Dated as of August 14, 2023

from 8-K 118 pages Agreement and Plan of Merger by and Among Harmony Biosciences Holdings, Inc., Xylophone Acquisition Corp. and Zynerba Pharmaceuticals, Inc. Dated as of August 14, 2023

from SC TO-C 118 pages Agreement and Plan of Merger by and Among Harmony Biosciences Holdings, Inc., Xylophone Acquisition Corp. and Zynerba Pharmaceuticals, Inc. Dated as of August 14, 2023